Key result
Formaldehyde-inactivated experimental vaccines from type 1 poliovirus live-attenuated strains showed differences in potency and specificity compared to wild-type IPV in normal and transgenic mice.
This study describes a novel transgenic mouse model and identifies differences in potency and specificity when using live-attenuated strains for inactivated polio vaccine production compared to wild-type strains.
Answers are grounded in this paper and cite their sources.
Potency differences in mice are hypothesis-generating for attenuated-strain IPV; should not yet influence vaccine development.
Formaldehyde-inactivated virus samples from type 1 poliovirus live-attenuated strains were prepared in the laboratory. The effect of treatment with formaldehyde on virus infectivity and immunogenicity in mice was investigated and the results compared with those from Mahoney wild-type poliovirus strain, the common type 1 component in commercial inactivated polio vaccines (IPV). Differences in the potency and specificity between these experimental vaccines were identified in both normal mice and transgenic mice expressing the human poliovirus receptor. The possible advantages/disadvantages of using live-attenuated strains for IPV production are discussed in the context of the global polio eradication initiative. A novel transgenic mouse model to study in vivo the immune protection induced by IPV preparations is described.
No takes yet. Share an insight, caveat, or question.
Martín et al. (2003) studied Poliovirus immunization. Formaldehyde-inactivated virus samples from type 1 poliovirus live-attenuated strains vs. Mahoney wild-type poliovirus strain was evaluated on Virus infectivity and immunogenicity (potency and specificity). Formaldehyde-inactivated experimental vaccines from type 1 poliovirus live-attenuated strains showed differences in potency and specificity compared to wild-type IPV in normal and transgenic mice.
Synapse has enriched 10 related papers. Consider them for comparative context: